Valued at USD 1.51 Bn in 2025, the market is projected to reach USD 2.84 Bn by 2034, growing at a 7.27% CAGR. North America holds the largest share, while Asia-Pacific grows fastest. The report profiles 10 companies.
The global quinine market was valued at USD 1.51 Bn in 2025 and is projected to reach USD 2.84 Bn by 2034, growing at a CAGR of 7.27%. North America is the largest regional market and Asia-Pacific is growing fastest.
Source: Custom Market Insights analysis.
To learn more about this report - request a sample report PDF
As per Custom Market Insights the Global Quinine Market, market was estimated at around USD 1.51 Billion in 2025 and is projected to witness a CAGR of 7.27% during 2025-2034, to reach around USD 2.84 Billion by 2034. The report examines the Quinine market’s drivers and restraints, as well as their impact analysis. Also, the report mentions global opportunities prevailing in the Quinine market.
To learn more about this report - request a sample report PDF
Quinine Market Overview
Quinine drug that is used for treating malaria and babesiosis. When artesunate is unavailable, Quinine is used to treat malaria caused by chloroquine-resistant Plasmodium falciparum. Although it is used to treat restless legs syndrome, it is not recommended for this use due to the risk of side effects. It can be administered intravenously or orally. Quinine resistance has been observed in some parts of the world. Quinine is also used to impart a bitter taste to tonic water. Quinine was used to treat malaria and other febrile conditions, leg cramps caused by vascular spasms, inner hemorrhoids, varicose veins, and pleural cavities after thoracoplasty.
Quinine Market: COVID–19 Impact Analysis
The COVID-19 pandemic is currently the world's largest and most serious health crisis. COVID-19 has no definitive treatment. Vaccine administration has begun in several countries, but no vaccine is completely effective. Several people are not protected even after vaccination, and some people cannot be vaccinated; therefore, research on COVID-19 treatment is still needed.
Chloroquine (CQ), as well as hydroxychloroquine (HCQ), as well as hydroxychloroquine (HCQ), are two of the drugs being studied. While both have strong activity against SARS-CoV-2, they have serious side effects. With its abundant natural ingredients, Indonesia has one potentially useful compound, Quinine sulphate (QS) that possesses the same structure and activity as CQ and HCQ but a better safety profile. Because hydroxychloroquine, a Quinine modification, is being used to treat COVID-19, the ancient malarial drug is regaining popularity. The market for Quinine thus witnessed a sharp upward trend during 2020 and is expected to witness growth throughout the forecast period.
Quinine Market: Growth Drivers
Increasing tonic water consumption
Tonic water is extensively consumed as a healthy drink around the world due to the presence of Quinine. This tonic water has outstanding medicinal properties and contains 83 milligrams of Quinine per liter. Market manufacturers now offer a wide variety of products with artificial sweeteners and flavors. Tonic water's medicinal benefits are also driving global demand for the product. The rise in demand for tonic water worldwide is propelling the growth of the Quinine market.
Rising cases of Malaria
While global attention has been concentrated on COVID-19, 14 million new cases of malaria were reported in 2020, and the number of incidents and deaths reported in the new WHO malaria report is the highest since 2012. The new WHO malaria report shows the highest incidences of cases and deaths since 2012, with most of those deaths, nearly 93 percent, occurring in Africa among children less than the age of five. Quinine is used for treating Plasmodium falciparum malaria, a parasite that enters the body's red blood cells and causes malaria. The drug works by either killing or preventing the parasite from growing. Thereby, the rising cases of malaria are anticipated to boost the demand for Quinine.
Quinine Market Segmentation Analysis
In our research scope, the Quinine market is segmented into type, application, administration, and end user. Based on type, in 2025, the 200 mg segment accounted for the biggest revenue share, and it is anticipated that it will continue to dominate during the projection period. Also, on the basis of application, the Quinine market is categorized into, problematic leg cramps, malaria, and others. Quinine sulphate is commonly used to treat painful leg cramps. For many years, a dose of 200-300 mg of Quinine sulphate was used to treat nocturnal leg cramps. These muscle cramps, which are usually idiopathic, are common, especially in older patients. Quinine may help by reducing motor end-plate excitability and expanding the muscle refractory period.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 1.51 Billion |
| Projected Market Size in 2034 | USD 2.84 Billion |
| CAGR Growth Rate | 7.27% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Prominent Players | Aecochem Corp, Haihang Industry Co. Ltd., Actavis, Shreeji Pharma International, Wockhardt, A. B. Enterprises, Trademax Pharmaceuticals & Chemicals , Caraco Pharmaceutical Laboratories, Hangzhou Dayang Co. Ltd., IS Chemical Technology Ltd., and Others |
| Key Segment | By Type, Application, Administration, End User, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Key Insights:
Recent Development
Regional Landscape
Geographically, the North America led the Quinine market in 2025 and will continue to grow significantly over the forecast period. Cinchona production is high, and the incidence of malaria and fever cases is increasing, which will cascade the sector's development over the forecast period. The trend is predicted to be closely followed by the Asia Pacific.
The Asia Pacific is expected to notice the most growth during the forecast period owing to increased healthcare spending, soaring disposable revenue resulting in better affordability, and surging patient preference for Quinine derivatives. The high population base in India enhanced patient knowledge of malaria and surged fever-causing diseases will drive market growth even further.
Competitive Landscape
The key players operating in the market hold the dominant market share. The report covers major strategic market developments such as acquisitions & mergers, partnerships, agreements, collaborations, joint ventures, new product launches, research and development, and regional expansion of major global and regional Quinine market players.
The global Quinine market is segmented as follows:
By Type
By Application
By Administration
By End User
On the basis of Geography
Updated: July 2026 · Formats: PDF, Excel, PPT
"North America" region will lead the global Quinine market during the forecast period 2025 to 2034.
Tonic water's medicinal benefits are also driving global demand for the product. The rise in demand for tonic water worldwide is propelling the growth of the Quinine market.
The key players operating in the Quinine market are Aecochem Corp, Haihang Industry Co. Ltd., Actavis, Shreeji Pharma International, Wockhardt, A. B. Enterprises, Trademax Pharmaceuticals & Chemicals, Caraco Pharmaceutical Laboratories, Hangzhou Dayang Co. Ltd., IS Chemical Technology Ltd., and Others.
The global Quinine market is expanding growth with a CAGR of approximately 7.27% during the forecast period (2025 to 2034).
The global Quinine market size was valued at USD 1.51 billion in 2025 and it is projected to reach around USD 2.84billion by 2034.
Author · Sr. Research Analyst
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
Buy individual chapters for $490 each: 9 chapters available, from Executive Summary to Company Profiles.
Get the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sample